Workflow
Anhui Guangxin Agrochemical (603599)
icon
Search documents
广信股份:股票连续三日收盘涨幅偏离值累计超20%
Xin Lang Cai Jing· 2026-01-29 09:25
Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% during three consecutive trading days from January 27 to 29, 2026 [1] Group 1: Company Operations - The company confirmed that its production and operations are normal, and there have been no significant adjustments in the internal or external environment [1] - The company, its controlling shareholder, and actual controller have no major events that could impact the abnormal stock price fluctuation [1] Group 2: Market Conditions - There have been no undisclosed significant matters that could affect the stock price, nor any media reports, market rumors, or sensitive information that could influence investor perception [1] - During the period of abnormal fluctuation, relevant personnel did not engage in buying or selling the company's stock [1] Group 3: Investor Advisory - The company reminds investors to be cautious and aware of trading risks associated with the stock price volatility [1]
农化制品板块1月28日涨2.01%,N农大领涨,主力资金净流入8.18亿元
Core Viewpoint - The agricultural chemical sector experienced a notable increase of 2.01% on January 28, with N Nongda leading the gains, reflecting positive market sentiment in this industry [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4151.24, up by 0.27%, while the Shenzhen Component Index closed at 14342.9, up by 0.09% [1]. - N Nongda's stock price surged to 52.89, marking an impressive increase of 111.56%, with a trading volume of 136,800 shares and a transaction value of 703 million yuan [1]. - Other notable performers included Hebang Biotechnology, which rose by 10.16% to 2.82, and Zhongnong United, which increased by 10.00% to 25.41 [1]. Group 2: Capital Flow - The agricultural chemical sector saw a net inflow of 818 million yuan from institutional investors, while retail investors experienced a net outflow of 163 million yuan [2]. - The main capital inflow was observed in Hebang Biotechnology, with a net inflow of 330 million yuan, while N Nongda had a net inflow of 71.85 million yuan [3]. - Conversely, ST Huifeng experienced a decline of 5.05% to 1.88, with a trading volume of 381,700 shares and a transaction value of approximately 72.16 million yuan [2].
广信股份股价涨5.44%,华夏基金旗下1只基金重仓,持有1849.23万股浮盈赚取1257.48万元
Xin Lang Cai Jing· 2026-01-22 05:22
Group 1 - Guangxin Co., Ltd. experienced a stock price increase of 5.44%, reaching 13.18 CNY per share, with a trading volume of 1.93 billion CNY and a turnover rate of 1.65%, resulting in a total market capitalization of 11.997 billion CNY [1] - The company, established on March 15, 2000, and listed on May 13, 2015, specializes in the research, production, and sales of pesticides and intermediates using phosgene as a raw material, with pesticide sales contributing 62.60% to revenue and intermediates and other products accounting for 37.13% [1] Group 2 - Huaxia Fund's Huaxia Industry Prosperity Mixed A Fund (003567) holds 18.4923 million shares of Guangxin Co., representing 2.03% of the circulating shares, with an estimated floating profit of approximately 12.5748 million CNY [2] - The fund, established on February 4, 2017, has a current scale of 6.958 billion CNY, with a year-to-date return of 9.08% and a one-year return of 72.03%, ranking 599 out of 8096 in its category [2] - The fund manager, Zhong Shuai, has a tenure of 5 years and 180 days, with the best fund return during this period being 212.68% and the worst being 9.85% [2]
草甘膦行业迎供需改善+格局重塑双重驱动,提前布局把握产业升级新机遇
Xin Lang Cai Jing· 2026-01-19 13:16
Core Viewpoint - The article discusses the impact of the upcoming export tax rebate cancellation on various companies in the glyphosate industry, highlighting their strategies to mitigate cost pressures and capitalize on market opportunities. Group 1: Company Strategies and Advantages - Xingfa Group, a leading player in the phosphate chemical industry, benefits from a complete supply chain and cost control, allowing it to quickly pass on cost pressures post-export tax rebate cancellation [1][19] - Yangnong Chemical, a leader in the biorational pesticide sector, plans to shift towards high-value formulation exports, leveraging its strong overseas registration and channel networks [2][20] - Hebang Biotechnology has a high self-sufficiency rate in raw materials, which helps it mitigate cost increases and capture orders during overseas inventory replenishment cycles [3][19] - Runfeng Co., a prominent pesticide exporter, can quickly adjust its product structure to high-value formulations, benefiting from its global partnerships and supply chain flexibility [4][20] - Xin'an Chemical, known for its integrated production model, significantly reduces costs and enhances flexibility in price transmission through its dual production of organic silicon and glyphosate [5][21] Group 2: Market Position and Growth Potential - Taihe Co. focuses on raw material production and aims to expand its market share by optimizing production costs and enhancing its domestic formulation market presence [6][22] - Andermatt Biocontrol, a global leader in pesticide formulations, plans to leverage its strong R&D capabilities and global network to maintain market leadership post-tax rebate changes [7][24] - Lier Chemical, with a complete R&D and production system, aims to enhance its market position through technological upgrades and a stable raw material supply chain [8][25] - Nopson, a leading pesticide formulation company, is expected to strengthen its domestic market position by quickly adapting to changes in export pressures [9][26] - Jiangshan Co., a top glyphosate producer, is positioned to benefit from its scale and technological advantages, allowing it to consolidate market share amid industry restructuring [10][28] Group 3: Industry Trends and Challenges - The glyphosate industry is experiencing consolidation, with companies poised to capture market share from smaller players exiting the market due to increased competition and regulatory pressures [11][29] - Companies are focusing on technological advancements and product iterations to address challenges such as glyphosate resistance and to enhance their competitive edge [12][30] - The shift towards high-value formulations and domestic market focus is a common strategy among companies to mitigate the impact of the export tax rebate cancellation [13][34]
广信股份:关于全资子公司通过高新技术企业认定的公告
Zheng Quan Ri Bao· 2026-01-19 12:37
证券日报网讯 1月19日,广信股份发布公告称,公司全资子公司安徽广信成辰科技有限公司(以下简 称"成辰科技")于近日收到安徽省工业和信息化厅、安徽省财政厅、国家税务总局安徽省税务局联合颁 发的编号为 GR202534000174 的《高新技术企业证书》,认定成辰科技为高新技术企业。发证日期为 2025 年 10月 28 日,有效期三年。 (文章来源:证券日报) ...
广信股份(603599) - 关于全资子公司通过高新技术企业认定的公告
2026-01-19 08:00
证券代码:603599 证券简称:广信股份 公告编号:2026-001 安徽广信农化股份有限公司 关于全资子公司通过高新技术企业认定的公告 安徽广信农化股份有限公司(以下简称"公司")全资子公司安徽广信成辰 科技有限公司(以下简称"成辰科技")于近日收到安徽省工业和信息化厅、安 徽省财政厅、国家税务总局安徽省税务局联合颁发的编号为 GR202534000174 的 《高新技术企业证书》,认定成辰科技为高新技术企业。发证日期为 2025 年 10 月 28 日,有效期三年。 成辰科技首次通过高新技术企业认定,根据《中华人民共和国企业所得税法》 等相关规定,成辰科技自通过高新技术企业认定起连续三年(2025 年至 2027 年) 将享受国家关于高新技术企业的税收优惠政策,即按 15%的税率缴纳企业所得税。 本次通过高新技术企业认定不会对公司当期经营业绩产生重大影响,敬请广 大投资者注意投资风险。 特此公告。 安徽广信农化股份有限公司董事会 2026 年 1 月 20 日 本公司董事会及全体董事保证本公司内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 ...
广信股份(603599.SH):全资子公司通过高新技术企业认定
Ge Long Hui A P P· 2026-01-19 07:58
格隆汇1月19日丨广信股份(603599.SH)公布,公司全资子公司安徽广信成辰科技有限公司(以下简 称"成辰科技")于近日收到安徽省工业和信息化厅、安徽省财政厅、国家税务总局安徽省税务局联合颁 发的编号为GR202534000174的《高新技术企业证书》,认定成辰科技为高新技术企业。发证日期为 2025年10月28日,有效期三年。成辰科技首次通过高新技术企业认定。 ...
广信股份:全资子公司通过高新技术企业认定
Ge Long Hui· 2026-01-19 07:54
格隆汇1月19日丨广信股份(603599.SH)公布,公司全资子公司安徽广信成辰科技有限公司(以下简 称"成辰科技")于近日收到安徽省工业和信息化厅、安徽省财政厅、国家税务总局安徽省税务局联合颁 发的编号为GR202534000174的《高新技术企业证书》,认定成辰科技为高新技术企业。发证日期为 2025年10月28日,有效期三年。成辰科技首次通过高新技术企业认定。 ...
农药行业点评报告:农药出口退税率取消或下调,行业反内卷持续深化
KAIYUAN SECURITIES· 2026-01-17 14:47
Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Viewpoints - The report highlights the impact of the recent cancellation and reduction of export tax rebates on pesticides, particularly focusing on the potential for price increases and improved profitability for leading companies in the pesticide sector [5] - The report anticipates a reversal in the pesticide industry's performance due to rising export costs and the upcoming spring farming season, which is expected to boost demand and prices [5] - The ongoing "anti-involution" trend in the pesticide industry is expected to optimize supply and reshape value, encouraging companies to shift from low-end manufacturing to a focus on technology, branding, and service [5] Summary by Relevant Sections Industry Overview - The pesticide industry is experiencing a significant shift due to policy changes, with the cancellation of export tax rebates for various pesticide raw materials and intermediates, including glyphosate and other high-toxicity products [4][5] - China is projected to export 2.05 million tons of pesticides in 2024, with exports accounting for 90% of production [5] Market Dynamics - The domestic pesticide production peak season occurs from February to May, with a significant increase in demand for pesticide formulations during this period [5] - The report notes that the price of 95% glyphosate raw powder has recently increased to 46,000 yuan per ton, indicating a recovery in pricing [11] Key Companies and Recommendations - Recommended stocks include leading pesticide companies such as Yangnong Chemical, Limin Co., and Xingfa Group, which are expected to benefit from the price increases and the integrated "raw material-formulation" model [5] - Beneficiary stocks also include Jiangshan Chemical, Lier Chemical, and others involved in various segments of the pesticide supply chain [5]
广信股份1月15日获融资买入1545.73万元,融资余额3.35亿元
Xin Lang Cai Jing· 2026-01-16 01:48
Core Viewpoint - Guangxin Co., Ltd. has experienced fluctuations in stock performance and financial metrics, with a notable decrease in revenue and net profit year-on-year, while maintaining a significant presence in the agricultural chemicals sector [1][2]. Group 1: Stock Performance - On January 15, Guangxin's stock rose by 3.04%, with a trading volume of 221 million yuan [1]. - The margin trading data indicated a financing buy of 15.46 million yuan and a repayment of 37.14 million yuan, resulting in a net financing outflow of 21.68 million yuan [1]. - As of January 15, the total margin trading balance for Guangxin was 336 million yuan, with the financing balance accounting for 3.02% of the circulating market value, indicating a high level compared to the past year [1]. Group 2: Financial Performance - For the period from January to September 2025, Guangxin reported a revenue of 2.663 billion yuan, reflecting a year-on-year decrease of 23.69% [2]. - The net profit attributable to shareholders was 520 million yuan, down 9.36% compared to the previous year [2]. - Since its A-share listing, Guangxin has distributed a total of 2.503 billion yuan in dividends, with 1.442 billion yuan distributed over the last three years [2]. Group 3: Shareholder Information - As of September 30, 2025, Guangxin had 19,100 shareholders, an increase of 24.31% from the previous period [2]. - The average number of circulating shares per shareholder was 47,778, which decreased by 19.56% compared to the last period [2]. - Notable institutional shareholders include招商核心竞争力混合A and 华夏行业景气混合A, with stable holdings, while 香港中央结算有限公司 increased its holdings by 2.6877 million shares [2].